MA30326B1 - Agent pour la prevention/le traitement du syndrome du colon irritable - Google Patents

Agent pour la prevention/le traitement du syndrome du colon irritable

Info

Publication number
MA30326B1
MA30326B1 MA31272A MA31272A MA30326B1 MA 30326 B1 MA30326 B1 MA 30326B1 MA 31272 A MA31272 A MA 31272A MA 31272 A MA31272 A MA 31272A MA 30326 B1 MA30326 B1 MA 30326B1
Authority
MA
Morocco
Prior art keywords
optionally substituted
treatment
substituted hydrocarbon
prevention
agent
Prior art date
Application number
MA31272A
Other languages
English (en)
Inventor
Jun Terauchi
Fumihiko Sato
Nobuhiro Inatomi
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38522471&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MA30326(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of MA30326B1 publication Critical patent/MA30326B1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/93—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems condensed with a ring other than six-membered
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Furan Compounds (AREA)

Abstract

La présente invention concerne un agent prophylactique ou thérapeutique pour le traitement du syndrome de l'intestin irritable, qui comprend un composé représenté par la formule (I) : dans laquelle, R1 représente un groupe hydrocarboné éventuellement substitué, etc., R2 représente un atome d'hydrogène ou un groupe hydrocarboné éventuellement substitué, R3 représente un atome d'hydrogène, un groupe hydrocarboné éventuellement substitué, etc., X représente CHR4, NR4, CO, O ou S (où R4 représente un atome d'hydrogène, un groupe hydrocarboné éventuellement substitué, etc.), Y représente C, CH ou N, ---- représente une simple liaison ou une double liaison, le cycle A représente un hétérocycle à 5 ou 7 chaînons éventuellement substitué contenant de l'oxygène, le cycle B représente un cycle benzène éventuellement substitué et m représente un nombre entier de 1 à 4, ou l'un de ses sels.
MA31272A 2006-03-20 2008-10-07 Agent pour la prevention/le traitement du syndrome du colon irritable MA30326B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2006076532 2006-03-20

Publications (1)

Publication Number Publication Date
MA30326B1 true MA30326B1 (fr) 2009-04-01

Family

ID=38522471

Family Applications (1)

Application Number Title Priority Date Filing Date
MA31272A MA30326B1 (fr) 2006-03-20 2008-10-07 Agent pour la prevention/le traitement du syndrome du colon irritable

Country Status (19)

Country Link
US (2) US20090048325A1 (fr)
EP (1) EP1997488A4 (fr)
JP (1) JP5219799B2 (fr)
KR (1) KR20080114743A (fr)
CN (1) CN101404994A (fr)
AR (1) AR059935A1 (fr)
AU (1) AU2007228087A1 (fr)
BR (1) BRPI0708805A2 (fr)
CA (1) CA2644181A1 (fr)
CR (1) CR10267A (fr)
IL (1) IL193686A0 (fr)
MA (1) MA30326B1 (fr)
MX (1) MX2008011969A (fr)
NO (1) NO20084214L (fr)
PE (1) PE20080122A1 (fr)
RU (1) RU2008141305A (fr)
TW (1) TW200803837A (fr)
WO (1) WO2007108442A1 (fr)
ZA (1) ZA200807752B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023059546A1 (fr) * 2021-10-04 2023-04-13 Psilosterics, Llc Agonistes du récepteur de la sérotonine et leurs méthodes de fabrication et d'utilisation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326192D0 (en) * 1993-12-22 1994-02-23 Glaxo Group Ltd Chemical compounds
JP2884153B2 (ja) * 1996-03-08 1999-04-19 武田薬品工業株式会社 三環性化合物、その製造法および剤
US6034239A (en) * 1996-03-08 2000-03-07 Takeda Chemical Industries, Ltd. Tricyclic compounds, their production and use
CA2241666C (fr) * 1996-03-08 2007-11-06 Takeda Chemical Industries, Ltd. Composes tricycliques, leur production et leur utilisation
DE69910795T2 (de) * 1998-06-09 2004-06-17 Takeda Chemical Industries, Ltd. Pharmazeutische kombination mit einer trizyclischen verbindung und mindestens einer von zolpidem, zopiclone und brotizolam, zur behandlung oder verhinderung von schlafstörungen
FR2795323B1 (fr) * 1999-06-23 2001-11-16 Adir Utilisation de ligands melatoninergiques pour l'obtention de compositions pharmaceutiques destinees a la prevention ou au traitement des pathologies du systeme gastrointestinal
JP2002226367A (ja) 2001-02-02 2002-08-14 Fuji Chem Ind Co Ltd 薬物障害の予防または治療剤
US20050203130A1 (en) * 2003-12-02 2005-09-15 Erik Buntinx Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists
AR056076A1 (es) * 2005-09-20 2007-09-19 Takeda Pharmaceutical Agente profilactico o terapeutico para el desorden de sueno
US20070088079A1 (en) * 2005-09-20 2007-04-19 Takeda Pharmaceutical Company Limited Prophylactic or therapeutic agent for sleep disorder
US8138174B2 (en) * 2007-01-10 2012-03-20 Solvay Pharmaceuticals B.V. Compounds with a combination of cannabinoid CB1 antagonism and serotonin reuptake inhibition

Also Published As

Publication number Publication date
IL193686A0 (en) 2009-08-03
CN101404994A (zh) 2009-04-08
CA2644181A1 (fr) 2007-09-27
PE20080122A1 (es) 2008-04-24
MX2008011969A (es) 2008-10-03
NO20084214L (no) 2008-10-08
AU2007228087A1 (en) 2007-09-27
US20100267821A1 (en) 2010-10-21
JPWO2007108442A1 (ja) 2009-08-06
RU2008141305A (ru) 2010-04-27
AR059935A1 (es) 2008-05-07
KR20080114743A (ko) 2008-12-31
US8183285B2 (en) 2012-05-22
TW200803837A (en) 2008-01-16
BRPI0708805A2 (pt) 2011-06-14
JP5219799B2 (ja) 2013-06-26
US20090048325A1 (en) 2009-02-19
CR10267A (es) 2008-11-18
ZA200807752B (en) 2009-12-30
EP1997488A1 (fr) 2008-12-03
WO2007108442A1 (fr) 2007-09-27
EP1997488A4 (fr) 2010-04-21

Similar Documents

Publication Publication Date Title
MA30890B1 (fr) Compose indole
MA29250B1 (fr) Cyclohexylamides servant d'antagonistes des recepteurs de dopamine d3, d2 et de 5ht1a
TNSN08337A1 (fr) Piperidinoylpyrrolidines agonistes du recepteur de melanocortine de type 4
HUP0203165A2 (hu) Nitrogént tartalmazó, öttagú heterociklusos vegyületek
MA32171B1 (fr) Compose heterocyclique
TN2009000204A1 (fr) Spirocetones servant d'inhibiteurs d'acetyl-coa-carboxylase
TNSN06358A1 (fr) Methyl-aryl-ou-heteroaryl-amides substitues
EA200600364A1 (ru) Производные (тио)карбамоилциклогексана в качестве антагонистов d/dрецептора
NO20052038L (no) Ny adeninforbindelse og anvendelse derav
MA30355B1 (fr) Derives d'azabicyclo [3. 1. 0] hexyle utilises comme modulateurs des recepteurs de la dopamine d3
MY153045A (en) Oxopyrazine derivative and herbicide
MA30911B1 (fr) Nouveaux derives de sulfonamide en tant qu'antagonistes de bradykinine
MA31710B1 (fr) (carboxylalkylenephenyl)phényloxamides, procédés pour la production de ceux-ci et utilisation de ceux-ci en tant que medicament
MA33832B1 (fr) Isoquinolinones et quinazolinones substituées
MA33209B1 (fr) Inhibiteurs de la replication du virus de l'hepatite c
EA200600527A1 (ru) Активирующее ppar соединение и содержащая его фармацевтическая композиция
MA32965B1 (fr) Derives de sulfonamides
MA32164B1 (fr) Derive heterocyclique fusionne et son utilisation
MA33581B1 (fr) Composition pharmaceutique contenant un dérivé de quinoléine
MA34361B1 (fr) Dérivés de tétrahydro-pyrido-pyrimidine
TR200103218T2 (tr) Yeni trisiklik bileçikler ve bunlarìn ila‡larda kullanìmì.
TW200745058A (en) MMP-13 selective inhibitors
MA32283B1 (fr) Composes cycliques condenses et utilisation de ceux-ci
MA33569B1 (fr) Ligands sigma pour la prevention ou le traitement de la douleur induite par la chimiotherapie
MA31323B1 (fr) Agents therapeutiques